nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—coronary artery disease—atherosclerosis	0.714	1	CtDrD
Ticagrelor—ABCB1—Ezetimibe—atherosclerosis	0.0316	0.152	CbGbCtD
Ticagrelor—ABCB1—Simvastatin—atherosclerosis	0.0294	0.141	CbGbCtD
Ticagrelor—ABCB1—Lovastatin—atherosclerosis	0.0288	0.138	CbGbCtD
Ticagrelor—ABCB1—Pravastatin—atherosclerosis	0.0288	0.138	CbGbCtD
Ticagrelor—CYP3A4—Rosuvastatin—atherosclerosis	0.0189	0.0909	CbGbCtD
Ticagrelor—CYP3A4—Ezetimibe—atherosclerosis	0.0189	0.0909	CbGbCtD
Ticagrelor—CYP3A4—Simvastatin—atherosclerosis	0.0176	0.0845	CbGbCtD
Ticagrelor—CYP3A4—Lovastatin—atherosclerosis	0.0172	0.0827	CbGbCtD
Ticagrelor—CYP3A4—Pravastatin—atherosclerosis	0.0172	0.0827	CbGbCtD
Ticagrelor—Lung disorder—Niacin—atherosclerosis	0.000922	0.0181	CcSEcCtD
Ticagrelor—Haemoptysis—Niacin—atherosclerosis	0.000882	0.0173	CcSEcCtD
Ticagrelor—Neoplasm malignant—Ezetimibe—atherosclerosis	0.000873	0.0171	CcSEcCtD
Ticagrelor—Bone disorder—Ezetimibe—atherosclerosis	0.000825	0.0162	CcSEcCtD
Ticagrelor—Gynaecomastia—Rosuvastatin—atherosclerosis	0.000802	0.0157	CcSEcCtD
Ticagrelor—Bone disorder—Niacin—atherosclerosis	0.000723	0.0142	CcSEcCtD
Ticagrelor—Renal failure acute—Rosuvastatin—atherosclerosis	0.000705	0.0138	CcSEcCtD
Ticagrelor—Hyperuricaemia—Niacin—atherosclerosis	0.000704	0.0138	CcSEcCtD
Ticagrelor—Gout—Niacin—atherosclerosis	0.000699	0.0137	CcSEcCtD
Ticagrelor—Gynaecomastia—Lovastatin—atherosclerosis	0.00068	0.0133	CcSEcCtD
Ticagrelor—Blood uric acid increased—Niacin—atherosclerosis	0.000665	0.013	CcSEcCtD
Ticagrelor—Gynaecomastia—Simvastatin—atherosclerosis	0.000636	0.0125	CcSEcCtD
Ticagrelor—Breast disorder—Rosuvastatin—atherosclerosis	0.000588	0.0115	CcSEcCtD
Ticagrelor—Gynaecomastia—Pravastatin—atherosclerosis	0.000575	0.0113	CcSEcCtD
Ticagrelor—Atrial fibrillation—Simvastatin—atherosclerosis	0.000545	0.0107	CcSEcCtD
Ticagrelor—Renal failure acute—Pravastatin—atherosclerosis	0.000505	0.00991	CcSEcCtD
Ticagrelor—Atrial fibrillation—Niacin—atherosclerosis	0.0005	0.00981	CcSEcCtD
Ticagrelor—Breast disorder—Ezetimibe—atherosclerosis	0.000489	0.00959	CcSEcCtD
Ticagrelor—Gastritis—Ezetimibe—atherosclerosis	0.000479	0.00939	CcSEcCtD
Ticagrelor—Haematuria—Rosuvastatin—atherosclerosis	0.000478	0.00938	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.000474	0.0093	CcSEcCtD
Ticagrelor—Gastritis—Simvastatin—atherosclerosis	0.000457	0.00896	CcSEcCtD
Ticagrelor—Mental disorder—Rosuvastatin—atherosclerosis	0.000395	0.00774	CcSEcCtD
Ticagrelor—Oedema peripheral—Ezetimibe—atherosclerosis	0.000369	0.00723	CcSEcCtD
Ticagrelor—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000368	0.00722	CcSEcCtD
Ticagrelor—Angioedema—Rosuvastatin—atherosclerosis	0.000358	0.00703	CcSEcCtD
Ticagrelor—Cough—Rosuvastatin—atherosclerosis	0.000342	0.00671	CcSEcCtD
Ticagrelor—Angiopathy—Ezetimibe—atherosclerosis	0.00034	0.00666	CcSEcCtD
Ticagrelor—Immune system disorder—Ezetimibe—atherosclerosis	0.000338	0.00663	CcSEcCtD
Ticagrelor—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000337	0.00662	CcSEcCtD
Ticagrelor—Haemoglobin—Niacin—atherosclerosis	0.000329	0.00646	CcSEcCtD
Ticagrelor—Mental disorder—Ezetimibe—atherosclerosis	0.000328	0.00643	CcSEcCtD
Ticagrelor—Haemorrhage—Niacin—atherosclerosis	0.000328	0.00643	CcSEcCtD
Ticagrelor—Malnutrition—Ezetimibe—atherosclerosis	0.000326	0.00639	CcSEcCtD
Ticagrelor—Oedema peripheral—Niacin—atherosclerosis	0.000323	0.00633	CcSEcCtD
Ticagrelor—Confusional state—Rosuvastatin—atherosclerosis	0.000323	0.00633	CcSEcCtD
Ticagrelor—Back pain—Lovastatin—atherosclerosis	0.000321	0.0063	CcSEcCtD
Ticagrelor—Back pain—Ezetimibe—atherosclerosis	0.000315	0.00618	CcSEcCtD
Ticagrelor—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000314	0.00616	CcSEcCtD
Ticagrelor—Mental disorder—Simvastatin—atherosclerosis	0.000313	0.00614	CcSEcCtD
Ticagrelor—Eye disorder—Niacin—atherosclerosis	0.000306	0.00601	CcSEcCtD
Ticagrelor—Angioedema—Lovastatin—atherosclerosis	0.000304	0.00596	CcSEcCtD
Ticagrelor—Cardiac disorder—Pravastatin—atherosclerosis	0.0003	0.00588	CcSEcCtD
Ticagrelor—Vertigo—Lovastatin—atherosclerosis	0.000298	0.00586	CcSEcCtD
Ticagrelor—Angioedema—Ezetimibe—atherosclerosis	0.000298	0.00584	CcSEcCtD
Ticagrelor—Angiopathy—Niacin—atherosclerosis	0.000297	0.00583	CcSEcCtD
Ticagrelor—Paraesthesia—Rosuvastatin—atherosclerosis	0.000287	0.00564	CcSEcCtD
Ticagrelor—Malnutrition—Niacin—atherosclerosis	0.000285	0.0056	CcSEcCtD
Ticagrelor—Cough—Ezetimibe—atherosclerosis	0.000284	0.00558	CcSEcCtD
Ticagrelor—Angioedema—Simvastatin—atherosclerosis	0.000284	0.00557	CcSEcCtD
Ticagrelor—Chest pain—Lovastatin—atherosclerosis	0.000283	0.00555	CcSEcCtD
Ticagrelor—Dyspepsia—Rosuvastatin—atherosclerosis	0.000282	0.00553	CcSEcCtD
Ticagrelor—Hypertension—Ezetimibe—atherosclerosis	0.000281	0.00552	CcSEcCtD
Ticagrelor—Vertigo—Simvastatin—atherosclerosis	0.000279	0.00548	CcSEcCtD
Ticagrelor—Chest pain—Ezetimibe—atherosclerosis	0.000277	0.00544	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000276	0.00541	CcSEcCtD
Ticagrelor—Constipation—Rosuvastatin—atherosclerosis	0.000274	0.00537	CcSEcCtD
Ticagrelor—Confusional state—Lovastatin—atherosclerosis	0.000273	0.00536	CcSEcCtD
Ticagrelor—Confusional state—Ezetimibe—atherosclerosis	0.000268	0.00526	CcSEcCtD
Ticagrelor—Chest pain—Simvastatin—atherosclerosis	0.000265	0.00519	CcSEcCtD
Ticagrelor—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000264	0.00517	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000262	0.00513	CcSEcCtD
Ticagrelor—Nervous system disorder—Ezetimibe—atherosclerosis	0.000261	0.00512	CcSEcCtD
Ticagrelor—Angioedema—Niacin—atherosclerosis	0.000261	0.00512	CcSEcCtD
Ticagrelor—Skin disorder—Ezetimibe—atherosclerosis	0.000258	0.00507	CcSEcCtD
Ticagrelor—Angioedema—Pravastatin—atherosclerosis	0.000257	0.00504	CcSEcCtD
Ticagrelor—Vertigo—Niacin—atherosclerosis	0.000256	0.00503	CcSEcCtD
Ticagrelor—Syncope—Niacin—atherosclerosis	0.000256	0.00502	CcSEcCtD
Ticagrelor—Confusional state—Simvastatin—atherosclerosis	0.000256	0.00502	CcSEcCtD
Ticagrelor—Abdominal pain—Rosuvastatin—atherosclerosis	0.000253	0.00496	CcSEcCtD
Ticagrelor—Vertigo—Pravastatin—atherosclerosis	0.000252	0.00495	CcSEcCtD
Ticagrelor—Loss of consciousness—Niacin—atherosclerosis	0.000251	0.00492	CcSEcCtD
Ticagrelor—Cough—Niacin—atherosclerosis	0.000249	0.00488	CcSEcCtD
Ticagrelor—Cough—Pravastatin—atherosclerosis	0.000245	0.00481	CcSEcCtD
Ticagrelor—Paraesthesia—Lovastatin—atherosclerosis	0.000243	0.00478	CcSEcCtD
Ticagrelor—Hypertension—Pravastatin—atherosclerosis	0.000243	0.00476	CcSEcCtD
Ticagrelor—Dyspnoea—Lovastatin—atherosclerosis	0.000242	0.00474	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000241	0.00473	CcSEcCtD
Ticagrelor—Chest pain—Pravastatin—atherosclerosis	0.000239	0.00469	CcSEcCtD
Ticagrelor—Paraesthesia—Ezetimibe—atherosclerosis	0.000239	0.00468	CcSEcCtD
Ticagrelor—Dyspepsia—Lovastatin—atherosclerosis	0.000239	0.00468	CcSEcCtD
Ticagrelor—Dyspnoea—Ezetimibe—atherosclerosis	0.000237	0.00465	CcSEcCtD
Ticagrelor—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000236	0.00462	CcSEcCtD
Ticagrelor—Dyspepsia—Ezetimibe—atherosclerosis	0.000234	0.00459	CcSEcCtD
Ticagrelor—Fatigue—Lovastatin—atherosclerosis	0.000234	0.00459	CcSEcCtD
Ticagrelor—Constipation—Lovastatin—atherosclerosis	0.000232	0.00455	CcSEcCtD
Ticagrelor—Confusional state—Pravastatin—atherosclerosis	0.000231	0.00454	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00023	0.0045	CcSEcCtD
Ticagrelor—Asthenia—Rosuvastatin—atherosclerosis	0.00023	0.0045	CcSEcCtD
Ticagrelor—Fatigue—Ezetimibe—atherosclerosis	0.000229	0.0045	CcSEcCtD
Ticagrelor—Shock—Niacin—atherosclerosis	0.000229	0.00449	CcSEcCtD
Ticagrelor—Paraesthesia—Simvastatin—atherosclerosis	0.000228	0.00447	CcSEcCtD
Ticagrelor—Constipation—Ezetimibe—atherosclerosis	0.000227	0.00446	CcSEcCtD
Ticagrelor—Pruritus—Rosuvastatin—atherosclerosis	0.000226	0.00444	CcSEcCtD
Ticagrelor—Skin disorder—Niacin—atherosclerosis	0.000226	0.00444	CcSEcCtD
Ticagrelor—Dyspnoea—Simvastatin—atherosclerosis	0.000226	0.00444	CcSEcCtD
Ticagrelor—Feeling abnormal—Lovastatin—atherosclerosis	0.000223	0.00438	CcSEcCtD
Ticagrelor—Dyspepsia—Simvastatin—atherosclerosis	0.000223	0.00438	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000222	0.00435	CcSEcCtD
Ticagrelor—Feeling abnormal—Ezetimibe—atherosclerosis	0.000219	0.0043	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000219	0.0043	CcSEcCtD
Ticagrelor—Diarrhoea—Rosuvastatin—atherosclerosis	0.000219	0.00429	CcSEcCtD
Ticagrelor—Fatigue—Simvastatin—atherosclerosis	0.000219	0.00429	CcSEcCtD
Ticagrelor—Hypotension—Niacin—atherosclerosis	0.000218	0.00427	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000217	0.00427	CcSEcCtD
Ticagrelor—Constipation—Simvastatin—atherosclerosis	0.000217	0.00425	CcSEcCtD
Ticagrelor—Abdominal pain—Lovastatin—atherosclerosis	0.000214	0.00421	CcSEcCtD
Ticagrelor—Body temperature increased—Lovastatin—atherosclerosis	0.000214	0.00421	CcSEcCtD
Ticagrelor—Dizziness—Rosuvastatin—atherosclerosis	0.000212	0.00415	CcSEcCtD
Ticagrelor—Abdominal pain—Ezetimibe—atherosclerosis	0.00021	0.00412	CcSEcCtD
Ticagrelor—Body temperature increased—Ezetimibe—atherosclerosis	0.00021	0.00412	CcSEcCtD
Ticagrelor—Paraesthesia—Niacin—atherosclerosis	0.000209	0.0041	CcSEcCtD
Ticagrelor—Feeling abnormal—Simvastatin—atherosclerosis	0.000209	0.0041	CcSEcCtD
Ticagrelor—Dyspnoea—Niacin—atherosclerosis	0.000208	0.00407	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000207	0.00407	CcSEcCtD
Ticagrelor—Paraesthesia—Pravastatin—atherosclerosis	0.000206	0.00404	CcSEcCtD
Ticagrelor—Dyspepsia—Niacin—atherosclerosis	0.000205	0.00402	CcSEcCtD
Ticagrelor—Dyspnoea—Pravastatin—atherosclerosis	0.000204	0.00401	CcSEcCtD
Ticagrelor—Dyspepsia—Pravastatin—atherosclerosis	0.000202	0.00396	CcSEcCtD
Ticagrelor—Rash—Rosuvastatin—atherosclerosis	0.000202	0.00396	CcSEcCtD
Ticagrelor—Dermatitis—Rosuvastatin—atherosclerosis	0.000202	0.00395	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Niacin—atherosclerosis	0.000201	0.00394	CcSEcCtD
Ticagrelor—Body temperature increased—Simvastatin—atherosclerosis	0.0002	0.00393	CcSEcCtD
Ticagrelor—Abdominal pain—Simvastatin—atherosclerosis	0.0002	0.00393	CcSEcCtD
Ticagrelor—Headache—Rosuvastatin—atherosclerosis	0.0002	0.00393	CcSEcCtD
Ticagrelor—Hypersensitivity—Lovastatin—atherosclerosis	0.0002	0.00392	CcSEcCtD
Ticagrelor—Fatigue—Pravastatin—atherosclerosis	0.000198	0.00388	CcSEcCtD
Ticagrelor—Constipation—Pravastatin—atherosclerosis	0.000196	0.00385	CcSEcCtD
Ticagrelor—Hypersensitivity—Ezetimibe—atherosclerosis	0.000196	0.00384	CcSEcCtD
Ticagrelor—Asthenia—Lovastatin—atherosclerosis	0.000195	0.00382	CcSEcCtD
Ticagrelor—Pruritus—Lovastatin—atherosclerosis	0.000192	0.00376	CcSEcCtD
Ticagrelor—Asthenia—Ezetimibe—atherosclerosis	0.000191	0.00374	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Niacin—atherosclerosis	0.00019	0.00374	CcSEcCtD
Ticagrelor—Nausea—Rosuvastatin—atherosclerosis	0.00019	0.00373	CcSEcCtD
Ticagrelor—Feeling abnormal—Pravastatin—atherosclerosis	0.000189	0.00371	CcSEcCtD
Ticagrelor—Pruritus—Ezetimibe—atherosclerosis	0.000188	0.00369	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000187	0.00368	CcSEcCtD
Ticagrelor—Hypersensitivity—Simvastatin—atherosclerosis	0.000187	0.00367	CcSEcCtD
Ticagrelor—Diarrhoea—Lovastatin—atherosclerosis	0.000186	0.00364	CcSEcCtD
Ticagrelor—Abdominal pain—Niacin—atherosclerosis	0.000184	0.00361	CcSEcCtD
Ticagrelor—Body temperature increased—Niacin—atherosclerosis	0.000184	0.00361	CcSEcCtD
Ticagrelor—Asthenia—Simvastatin—atherosclerosis	0.000182	0.00357	CcSEcCtD
Ticagrelor—Diarrhoea—Ezetimibe—atherosclerosis	0.000182	0.00357	CcSEcCtD
Ticagrelor—Abdominal pain—Pravastatin—atherosclerosis	0.000181	0.00356	CcSEcCtD
Ticagrelor—Body temperature increased—Pravastatin—atherosclerosis	0.000181	0.00356	CcSEcCtD
Ticagrelor—Pruritus—Simvastatin—atherosclerosis	0.000179	0.00352	CcSEcCtD
Ticagrelor—Dizziness—Lovastatin—atherosclerosis	0.000179	0.00352	CcSEcCtD
Ticagrelor—Dizziness—Ezetimibe—atherosclerosis	0.000176	0.00345	CcSEcCtD
Ticagrelor—Diarrhoea—Simvastatin—atherosclerosis	0.000174	0.0034	CcSEcCtD
Ticagrelor—Vomiting—Lovastatin—atherosclerosis	0.000172	0.00338	CcSEcCtD
Ticagrelor—Hypersensitivity—Niacin—atherosclerosis	0.000172	0.00337	CcSEcCtD
Ticagrelor—Rash—Lovastatin—atherosclerosis	0.000171	0.00335	CcSEcCtD
Ticagrelor—Dermatitis—Lovastatin—atherosclerosis	0.000171	0.00335	CcSEcCtD
Ticagrelor—Headache—Lovastatin—atherosclerosis	0.00017	0.00333	CcSEcCtD
Ticagrelor—Vomiting—Ezetimibe—atherosclerosis	0.000169	0.00332	CcSEcCtD
Ticagrelor—Hypersensitivity—Pravastatin—atherosclerosis	0.000169	0.00331	CcSEcCtD
Ticagrelor—Dizziness—Simvastatin—atherosclerosis	0.000168	0.00329	CcSEcCtD
Ticagrelor—Rash—Ezetimibe—atherosclerosis	0.000168	0.00329	CcSEcCtD
Ticagrelor—Dermatitis—Ezetimibe—atherosclerosis	0.000168	0.00329	CcSEcCtD
Ticagrelor—Asthenia—Niacin—atherosclerosis	0.000167	0.00328	CcSEcCtD
Ticagrelor—Headache—Ezetimibe—atherosclerosis	0.000167	0.00327	CcSEcCtD
Ticagrelor—Pruritus—Niacin—atherosclerosis	0.000165	0.00323	CcSEcCtD
Ticagrelor—Asthenia—Pravastatin—atherosclerosis	0.000165	0.00323	CcSEcCtD
Ticagrelor—Pruritus—Pravastatin—atherosclerosis	0.000162	0.00318	CcSEcCtD
Ticagrelor—Vomiting—Simvastatin—atherosclerosis	0.000161	0.00316	CcSEcCtD
Ticagrelor—Nausea—Lovastatin—atherosclerosis	0.000161	0.00316	CcSEcCtD
Ticagrelor—Rash—Simvastatin—atherosclerosis	0.00016	0.00314	CcSEcCtD
Ticagrelor—Dermatitis—Simvastatin—atherosclerosis	0.00016	0.00313	CcSEcCtD
Ticagrelor—Diarrhoea—Niacin—atherosclerosis	0.000159	0.00313	CcSEcCtD
Ticagrelor—Headache—Simvastatin—atherosclerosis	0.000159	0.00312	CcSEcCtD
Ticagrelor—Nausea—Ezetimibe—atherosclerosis	0.000158	0.0031	CcSEcCtD
Ticagrelor—Diarrhoea—Pravastatin—atherosclerosis	0.000157	0.00308	CcSEcCtD
Ticagrelor—Dizziness—Niacin—atherosclerosis	0.000154	0.00302	CcSEcCtD
Ticagrelor—Dizziness—Pravastatin—atherosclerosis	0.000152	0.00297	CcSEcCtD
Ticagrelor—Nausea—Simvastatin—atherosclerosis	0.000151	0.00296	CcSEcCtD
Ticagrelor—Vomiting—Niacin—atherosclerosis	0.000148	0.0029	CcSEcCtD
Ticagrelor—Rash—Niacin—atherosclerosis	0.000147	0.00288	CcSEcCtD
Ticagrelor—Dermatitis—Niacin—atherosclerosis	0.000147	0.00288	CcSEcCtD
Ticagrelor—Headache—Niacin—atherosclerosis	0.000146	0.00286	CcSEcCtD
Ticagrelor—Vomiting—Pravastatin—atherosclerosis	0.000146	0.00286	CcSEcCtD
Ticagrelor—Rash—Pravastatin—atherosclerosis	0.000145	0.00284	CcSEcCtD
Ticagrelor—Dermatitis—Pravastatin—atherosclerosis	0.000144	0.00283	CcSEcCtD
Ticagrelor—Headache—Pravastatin—atherosclerosis	0.000144	0.00282	CcSEcCtD
Ticagrelor—Nausea—Niacin—atherosclerosis	0.000138	0.00271	CcSEcCtD
Ticagrelor—Nausea—Pravastatin—atherosclerosis	0.000136	0.00267	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	5.9e-05	0.0022	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—FASLG—atherosclerosis	5.78e-05	0.00216	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL3—atherosclerosis	5.76e-05	0.00215	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR2—atherosclerosis	5.73e-05	0.00214	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—EDNRA—atherosclerosis	5.73e-05	0.00214	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—F2—atherosclerosis	5.61e-05	0.00209	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—GHRL—atherosclerosis	5.59e-05	0.00209	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	5.57e-05	0.00208	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PDGFB—atherosclerosis	5.56e-05	0.00208	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	5.5e-05	0.00205	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MMP1—atherosclerosis	5.5e-05	0.00205	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOA4—atherosclerosis	5.4e-05	0.00202	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	5.38e-05	0.00201	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—CAV1—atherosclerosis	5.27e-05	0.00197	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	5.27e-05	0.00197	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—APOA1—atherosclerosis	5.26e-05	0.00196	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	5.24e-05	0.00196	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR2—atherosclerosis	5.21e-05	0.00194	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EDNRA—atherosclerosis	5.21e-05	0.00194	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	5.19e-05	0.00194	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	5.11e-05	0.00191	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—GHRL—atherosclerosis	5.07e-05	0.00189	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—F2—atherosclerosis	5.02e-05	0.00187	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL2—atherosclerosis	5e-05	0.00187	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL4—atherosclerosis	4.98e-05	0.00186	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	4.97e-05	0.00186	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS2—atherosclerosis	4.96e-05	0.00185	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	4.91e-05	0.00183	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—KNG1—atherosclerosis	4.91e-05	0.00183	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AGTR1—atherosclerosis	4.88e-05	0.00182	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CG—atherosclerosis	4.8e-05	0.00179	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOA2—atherosclerosis	4.65e-05	0.00174	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	4.63e-05	0.00173	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	4.6e-05	0.00172	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	4.54e-05	0.00169	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KNG1—atherosclerosis	4.45e-05	0.00166	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—UTS2—atherosclerosis	4.44e-05	0.00166	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGTR1—atherosclerosis	4.43e-05	0.00165	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IGF1—atherosclerosis	4.4e-05	0.00164	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	4.29e-05	0.0016	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CX3CR1—atherosclerosis	4.25e-05	0.00159	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASR—atherosclerosis	4.25e-05	0.00159	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SERPINE1—atherosclerosis	4.17e-05	0.00156	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CX3CL1—atherosclerosis	4.17e-05	0.00156	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—atherosclerosis	4.17e-05	0.00156	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—EDN1—atherosclerosis	4.13e-05	0.00154	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	4.11e-05	0.00154	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCL5—atherosclerosis	4.1e-05	0.00153	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS3—atherosclerosis	3.99e-05	0.00149	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	3.97e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CNR2—atherosclerosis	3.96e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL8—atherosclerosis	3.95e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MMP3—atherosclerosis	3.95e-05	0.00147	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PRKCG—atherosclerosis	3.9e-05	0.00146	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EDN1—atherosclerosis	3.75e-05	0.0014	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL5—atherosclerosis	3.72e-05	0.00139	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IFNG—atherosclerosis	3.65e-05	0.00136	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	3.55e-05	0.00133	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PRKCG—atherosclerosis	3.54e-05	0.00132	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VWF—atherosclerosis	3.53e-05	0.00132	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOC3—atherosclerosis	3.5e-05	0.00131	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LDLR—atherosclerosis	3.48e-05	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AGT—atherosclerosis	3.43e-05	0.00128	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL3—atherosclerosis	3.4e-05	0.00127	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	3.4e-05	0.00127	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—atherosclerosis	3.26e-05	0.00122	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NCF1—atherosclerosis	3.26e-05	0.00122	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	3.25e-05	0.00121	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	3.2e-05	0.00119	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	3.19e-05	0.00119	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—F2—atherosclerosis	3.17e-05	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGT—atherosclerosis	3.12e-05	0.00116	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDNRA—atherosclerosis	3.08e-05	0.00115	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR2—atherosclerosis	3.08e-05	0.00115	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CYBA—atherosclerosis	3.06e-05	0.00114	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CG—atherosclerosis	3.03e-05	0.00113	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLAT—atherosclerosis	3e-05	0.00112	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PARP1—atherosclerosis	3e-05	0.00112	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GHRL—atherosclerosis	3e-05	0.00112	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	2.95e-05	0.0011	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—F2—atherosclerosis	2.88e-05	0.00107	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—atherosclerosis	2.87e-05	0.00107	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	2.85e-05	0.00106	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	2.76e-05	0.00103	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CG—atherosclerosis	2.76e-05	0.00103	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAPK3—atherosclerosis	2.72e-05	0.00101	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	2.65e-05	0.00099	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TGFB1—atherosclerosis	2.64e-05	0.000984	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KNG1—atherosclerosis	2.63e-05	0.000982	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGTR1—atherosclerosis	2.62e-05	0.000977	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL2—atherosclerosis	2.57e-05	0.000958	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	2.55e-05	0.000953	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PLG—atherosclerosis	2.55e-05	0.000952	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	2.53e-05	0.000945	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SOCS3—atherosclerosis	2.41e-05	0.000901	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	2.41e-05	0.000899	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—atherosclerosis	2.36e-05	0.000883	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LDLRAP1—atherosclerosis	2.36e-05	0.000883	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP3—atherosclerosis	2.33e-05	0.00087	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF2—atherosclerosis	2.32e-05	0.000867	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOB—atherosclerosis	2.25e-05	0.000841	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—atherosclerosis	2.23e-05	0.000834	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLTP—atherosclerosis	2.22e-05	0.00083	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDN1—atherosclerosis	2.22e-05	0.000828	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL5—atherosclerosis	2.2e-05	0.000822	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LPL—atherosclerosis	2.15e-05	0.000803	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKCG—atherosclerosis	2.09e-05	0.000781	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	2.08e-05	0.000778	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.05e-05	0.000767	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SPP1—atherosclerosis	2.04e-05	0.000761	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	2.03e-05	0.000759	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—atherosclerosis	2.03e-05	0.000757	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.03e-05	0.000756	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG8—atherosclerosis	1.93e-05	0.000719	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LTA4H—atherosclerosis	1.93e-05	0.000719	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	1.89e-05	0.000705	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDGFB—atherosclerosis	1.89e-05	0.000704	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGT—atherosclerosis	1.84e-05	0.000687	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT1—atherosclerosis	1.83e-05	0.000684	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOE—atherosclerosis	1.8e-05	0.000673	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—atherosclerosis	1.8e-05	0.000673	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CAV1—atherosclerosis	1.79e-05	0.000667	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOA1—atherosclerosis	1.78e-05	0.000666	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	1.73e-05	0.000645	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ESR1—atherosclerosis	1.72e-05	0.000643	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—F2—atherosclerosis	1.7e-05	0.000635	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.66e-05	0.000622	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CG—atherosclerosis	1.63e-05	0.000608	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK3—atherosclerosis	1.56e-05	0.000582	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—INS—atherosclerosis	1.54e-05	0.000575	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG1—atherosclerosis	1.52e-05	0.000569	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL2—atherosclerosis	1.52e-05	0.000566	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.5e-05	0.00056	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—atherosclerosis	1.49e-05	0.000556	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.47e-05	0.000551	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.46e-05	0.000544	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LCAT—atherosclerosis	1.43e-05	0.000535	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FABP4—atherosclerosis	1.43e-05	0.000535	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.42e-05	0.000529	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SERPINE1—atherosclerosis	1.42e-05	0.000528	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA4—atherosclerosis	1.41e-05	0.000525	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.38e-05	0.000516	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLTP—atherosclerosis	1.37e-05	0.000511	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.36e-05	0.000508	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—atherosclerosis	1.35e-05	0.000504	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.31e-05	0.000488	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.29e-05	0.000481	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.28e-05	0.000477	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.25e-05	0.000467	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.25e-05	0.000467	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.21e-05	0.000452	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX15—atherosclerosis	1.21e-05	0.000452	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA2—atherosclerosis	1.21e-05	0.000452	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.21e-05	0.000452	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—atherosclerosis	1.2e-05	0.000447	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG5—atherosclerosis	1.2e-05	0.000446	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.19e-05	0.000443	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.19e-05	0.000443	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.17e-05	0.000436	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—atherosclerosis	1.16e-05	0.000432	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPA—atherosclerosis	1.15e-05	0.000431	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—atherosclerosis	1.14e-05	0.000425	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BGN—atherosclerosis	1.12e-05	0.000417	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA5—atherosclerosis	1.11e-05	0.000413	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—atherosclerosis	1.08e-05	0.000405	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFKB1—atherosclerosis	1.07e-05	0.0004	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.07e-05	0.000398	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.06e-05	0.000394	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK8—atherosclerosis	1.05e-05	0.000394	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—atherosclerosis	1.05e-05	0.000393	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX5—atherosclerosis	1.03e-05	0.000384	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	9.9e-06	0.00037	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—atherosclerosis	9.73e-06	0.000363	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—atherosclerosis	9.64e-06	0.00036	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.38e-06	0.00035	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NAMPT—atherosclerosis	9.23e-06	0.000345	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK3—atherosclerosis	9.21e-06	0.000344	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LIPC—atherosclerosis	9.17e-06	0.000342	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOC3—atherosclerosis	9.11e-06	0.00034	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LDLR—atherosclerosis	9.06e-06	0.000338	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—atherosclerosis	8.93e-06	0.000334	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CETP—atherosclerosis	8.85e-06	0.00033	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FABP4—atherosclerosis	8.82e-06	0.000329	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LCAT—atherosclerosis	8.82e-06	0.000329	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.69e-06	0.000324	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA4—atherosclerosis	8.66e-06	0.000323	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.51e-06	0.000318	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SCARB1—atherosclerosis	8.47e-06	0.000316	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMGCR—atherosclerosis	8e-06	0.000299	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.86e-06	0.000294	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.84e-06	0.000293	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.46e-06	0.000278	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.46e-06	0.000278	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA2—atherosclerosis	7.46e-06	0.000278	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.46e-06	0.000278	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.36e-06	0.000275	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCA1—atherosclerosis	7.13e-06	0.000266	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPA—atherosclerosis	7.11e-06	0.000266	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BGN—atherosclerosis	6.89e-06	0.000257	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA5—atherosclerosis	6.82e-06	0.000255	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—atherosclerosis	6.73e-06	0.000251	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.56e-06	0.000245	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.34e-06	0.000237	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—atherosclerosis	6.21e-06	0.000232	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HMOX1—atherosclerosis	6.12e-06	0.000228	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOB—atherosclerosis	5.86e-06	0.000219	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—atherosclerosis	5.7e-06	0.000213	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.69e-06	0.000212	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LIPC—atherosclerosis	5.65e-06	0.000211	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOC3—atherosclerosis	5.61e-06	0.00021	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LPL—atherosclerosis	5.6e-06	0.000209	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LDLR—atherosclerosis	5.58e-06	0.000208	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPX1—atherosclerosis	5.46e-06	0.000204	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CETP—atherosclerosis	5.45e-06	0.000204	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CD36—atherosclerosis	5.32e-06	0.000199	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.22e-06	0.000195	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—atherosclerosis	5.04e-06	0.000188	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARA—atherosclerosis	4.94e-06	0.000185	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.93e-06	0.000184	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AGT—atherosclerosis	4.79e-06	0.000179	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOE—atherosclerosis	4.69e-06	0.000175	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAV1—atherosclerosis	4.65e-06	0.000174	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA1—atherosclerosis	4.64e-06	0.000173	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.39e-06	0.000164	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.23e-06	0.000158	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARG—atherosclerosis	4.09e-06	0.000153	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—INS—atherosclerosis	4.01e-06	0.00015	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.77e-06	0.000141	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—atherosclerosis	3.67e-06	0.000137	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOB—atherosclerosis	3.61e-06	0.000135	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—atherosclerosis	3.51e-06	0.000131	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.51e-06	0.000131	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LPL—atherosclerosis	3.45e-06	0.000129	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPX1—atherosclerosis	3.36e-06	0.000126	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CD36—atherosclerosis	3.28e-06	0.000122	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—atherosclerosis	3.21e-06	0.00012	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.1e-06	0.000116	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARA—atherosclerosis	3.05e-06	0.000114	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AGT—atherosclerosis	2.95e-06	0.00011	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOE—atherosclerosis	2.89e-06	0.000108	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAV1—atherosclerosis	2.86e-06	0.000107	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA1—atherosclerosis	2.86e-06	0.000107	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.61e-06	9.74e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARG—atherosclerosis	2.52e-06	9.4e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—INS—atherosclerosis	2.47e-06	9.22e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—atherosclerosis	2.26e-06	8.45e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—atherosclerosis	2.17e-06	8.08e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.98e-06	7.39e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—atherosclerosis	1.62e-06	6.03e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—atherosclerosis	9.95e-07	3.72e-05	CbGpPWpGaD
